| Literature DB >> 35196315 |
Shivohum Bahuguna, Magda Atilano, Marcus Glittenberg, Dohun Lee, Srishti Arora, Lihui Wang, Jun Zhou, Siamak Redhai, Michael Boutros, Petros Ligoxygakis.
Abstract
[This corrects the article DOI: 10.1371/journal.pgen.1009992.].Entities:
Year: 2022 PMID: 35196315 PMCID: PMC8865663 DOI: 10.1371/journal.pgen.1010082
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Fig 6Loss of PGRP-SA increases intestinal fat levels.
Loss of PGRP-SA increased intestinal triglyceride levels in 5-day old flies. This phenomenon was suppressed with pharmacological inhibition (rapamycin) or RNAi against TOR in ECs. This was dependent on 4EBP as yw seml; NP1>4E-BP treated with rapamycin had fat levels statistically indistinguishable from yw seml. N = 15/genotype/treatment a total of three independent experiments (each with n = 5/genotype/treatment). Values of mutants and controls were statistically compared using student’s t-test (***p<0.001, all other comparisons non-significant except yw seml; NP1>4E-BP treated with rapamycin compared to yw, which has a p value<0.001-comparison not shown in the graph).